We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App





Self-Assembling Nanoparticle Technology Could Be Game Changer for COVID-19 Vaccine Development

By HospiMedica International staff writers
Posted on 16 May 2020
Print article
Image: An atomic model of one of the NSP Covid-19 Nanoparticle vaccine candidates displaying the SARS CoV-2 spike protein (Photo courtesy of Predictive Oncology)
Image: An atomic model of one of the NSP Covid-19 Nanoparticle vaccine candidates displaying the SARS CoV-2 spike protein (Photo courtesy of Predictive Oncology)
A ground-breaking novel nanoparticle vaccine technology based on a self-assembling nanoparticle could prove to be a game changer for the development of a COVID-19 vaccine.

The novel nanoparticle vaccine technology platform recently developed by Dr. Daniel Carter is based on a self-assembling nanoparticle called NSP10 which has special surface properties that allow for the rapid design and display of viral receptor stems for virtually any virus, making it extremely versatile. The novel nanoparticle vaccine technology platform has been licensed to Predictive Oncology (Minneapolis, MN, USA), which has entered the race to develop a COVID19 vaccine.

Previous vaccine studies of NSP10-based Nanoparticles in rabbits produced exceptionally high titers against a herpes viral protein called glycoprotein D, normally non-highly antigenic (Titer refers to the number of times the blood serum can be diluted and still react with the virus antigen). Titers in this case ranged from 1:1,000 with a simple injection of 500 micrograms of plasmid DNA, to as much as 1:25,000 after a second booster (third injection) - all without the use of adjuvants or transfection agents. This is unprecedented and revolutionary for a DNA vaccine. The exact reasons why the NSP10-based Nanoparticles exhibit these properties is still a subject of study, but scientists know that nanoparticles are processed differently by the immune system and smaller nanoparticles can often produce higher titers – NSP is one of the smallest currently evaluated.

The level of titer is important for many reasons, for example, earlier animal experiments with vaccines focused on severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) found that low antibody levels could potentially lead to dysfunctional immune responses, increasing infection and damaging the lungs. In addition to enhanced protective immunity, stronger titers mean that it takes less vaccine per dose which has added advantages in safety and production scale. In the case of NSP10-based vaccines, as it translates to humans, this could mean that a single gram of plasmid DNA can potentially immunize as many as 2,000 people, perhaps more.

According to Dr. Carter, “this suggests that if we see similar titers in humans, no atypical resources or capabilities are required to manufacture the vaccine at a sufficient scale to impact the pandemic.” For example, a single bacterial fermentation at commercial scale can in a span of two to three days, produce enough raw material to eventually immunize millions of people - “merge this with the well-established processes for purifying injectable-grade plasmid DNA (which can also be done in short order) and you have the potential for a disruptive game changing technology,” added Dr. Carter.

Related Links:
Predictive Oncology

Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Bilirubin Lamp
Bilibluelight

Print article

Channels

Critical Care

view channel
Image: The permeable wearable electronics developed for long-term biosignal monitoring (Photo courtesy of CityUHK)

Super Permeable Wearable Electronics Enable Long-Term Biosignal Monitoring

Wearable electronics have become integral to enhancing health and fitness by offering continuous tracking of physiological signals over extended periods. This monitoring is crucial for understanding an... Read more

Surgical Techniques

view channel
Image: NTT and Olympus have begun the world\'s first joint demonstration experiment of a cloud endoscopy system (Photo courtesy of Olympus)

Cloud Endoscopy System Enables Real-Time Image Processing on the Cloud

Endoscopes, which are flexible tubes inserted into the body's natural openings for internal examination and biopsy collection, are becoming increasingly vital in medical diagnostics. Their minimal invasiveness... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The PATHFAST hs-cTnI-II high-sensitivity troponin assay has been developed for the PATHFAST Biomarker Analyzer (Photo courtesy of Polymedco)

POC Myocardial Infarction Test Delivers Results in 17 Minutes

Chest pain is the second leading cause of emergency department (ED) visits by adults in the United States, generating over 7 million visits annually. In the event of a suspected heart attack, physicians... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.